…
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
HCA Healthcare operates a large network of hospitals, surgery centers and emergency rooms providing acute and ambulatory care across the U.S. and U.K. Long-term growth may be supported by demographic trends, expansion of outpatient services and scale-driven efficiency.
Key risks include reimbursement pressure from government and private payers, regulatory and compliance exposure, rising labor and input costs, and capital intensity that could affect margins and cash flow.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 9832.00M | 8523.00M | 7706.00M | 8580.00M | 9833.00M |
| Minority interest | -998.00M | -897.00M | -849.00M | -1191.00M | -765.00M |
| Net income | 6784.00M | 5760.00M | 5242.00M | 5643.00M | 6956.00M |
| Selling general administrative | 7997.00M | 31170.00M | 29487.00M | 27685.00M | 26779.00M |
| Gross profit | 31374.00M | 28678.00M | 25579.00M | 50862.00M | 49271.00M |
| Reconciled depreciation | 3523.00M | 3312.00M | 3077.00M | 2969.00M | 2853.00M |
| Ebit | 12080.00M | 10584.00M | 9644.00M | 9098.00M | 9791.00M |
| Ebitda | 15603.00M | 13896.00M | 12721.00M | 12067.00M | 12644.00M |
| Depreciation and amortization | 3523.00M | 3312.00M | 3077.00M | 2969.00M | 2853.00M |
| Non operating income net other | - | - | - | 1268.00M | 1721.00M |
| Operating income | 11965.00M | 10547.00M | 9627.00M | 9098.00M | 9791.00M |
| Other operating expenses | 63635.00M | 60056.00M | 55341.00M | 51180.00M | 49074.00M |
| Interest expense | 2248.00M | 2061.00M | 1938.00M | 1741.00M | 1566.00M |
| Tax provision | 2050.00M | 1866.00M | 1615.00M | 1746.00M | 2112.00M |
| Interest income | 2170.00M | 2038.00M | 1916.00M | 1696.00M | 1453.00M |
| Net interest income | -2248.00M | -2061.00M | -1938.00M | -1741.00M | -1566.00M |
| Income tax expense | 2050.00M | 1866.00M | 1615.00M | 1746.00M | 2112.00M |
| Total revenue | 75600.00M | 70603.00M | 64968.00M | 60233.00M | 58752.00M |
| Total operating expenses | 19409.00M | 18131.00M | 15952.00M | 41809.00M | 39593.00M |
| Cost of revenue | 44226.00M | 41925.00M | 39389.00M | 9371.00M | 9481.00M |
| Total other income expense net | -2133.00M | -2024.00M | -1921.00M | -518.00M | 42.00M |
| Net income from continuing ops | 7782.00M | 6657.00M | 6091.00M | 6834.00M | 7721.00M |
| Net income applicable to common shares | 6784.00M | 5760.00M | 5242.00M | 5643.00M | 6956.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 60720.00M | 59513.00M | 56211.00M | 52438.00M | 50742.00M |
| Intangible assets | 10293.00M | 323.00M | 339.00M | 9653.00M | 9540.00M |
| Other current assets | 2224.00M | 1904.00M | 2013.00M | 1776.00M | 2010.00M |
| Total liab | 63491.00M | 58958.00M | 55151.00M | 52511.00M | 49253.00M |
| Total stockholder equity | -2771.00M | 555.00M | 1060.00M | -2767.00M | -933.00M |
| Other current liab | 2730.00M | 5441.00M | 5253.00M | 5293.00M | 5234.00M |
| Common stock | 2.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Capital stock | 2.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Retained earnings | -5724.00M | -2115.00M | -1352.00M | -2280.00M | -532.00M |
| Other liab | - | - | - | 3143.00M | 3574.00M |
| Good will | 10275.00M | 9770.00M | 9606.00M | 9653.00M | 9540.00M |
| Other assets | 255.00M | 230.00M | 184.00M | 298.00M | 598.00M |
| Cash | 1040.00M | 1933.00M | 935.00M | 908.00M | 1451.00M |
| Cash and equivalents | 1040.00M | 1933.00M | 935.00M | 908.00M | 1451.00M |
| Total current liabilities | 16350.00M | 15177.00M | 12655.00M | 9902.00M | 9582.00M |
| Current deferred revenue | - | - | 2109.00M | - | - |
| Net debt | 49158.00M | 43304.00M | 40924.00M | 38928.00M | 34883.00M |
| Short term debt | 5241.00M | 5041.00M | 2787.00M | 370.00M | 237.00M |
| Short long term debt | 4889.00M | 4698.00M | 2424.00M | 370.00M | 237.00M |
| Short long term debt total | 48697.00M | 45237.00M | 41859.00M | 39836.00M | 36334.00M |
| Other stockholder equity | -6027.00M | 2502.00M | -403.00M | 2767.00M | 933.00M |
| Property plant equipment | 33271.00M | 31545.00M | 29922.00M | 27640.00M | 26176.00M |
| Total current assets | 13559.00M | 16414.00M | 14927.00M | 13643.00M | 13542.00M |
| Long term investments | 1118.00M | 1231.00M | 1233.00M | 1204.00M | 886.00M |
| Net tangible assets | - | - | - | -10668.00M | -10473.00M |
| Short term investments | - | 88.00M | 87.00M | 381.00M | 438.00M |
| Net receivables | 10867.00M | 10751.00M | 9958.00M | 8891.00M | 8095.00M |
| Long term debt | 41603.00M | 38333.00M | 37169.00M | 37714.00M | 34342.00M |
| Inventory | 1652.00M | 1738.00M | 2021.00M | 2068.00M | 1986.00M |
| Accounts payable | 4659.00M | 4276.00M | 4233.00M | 4239.00M | 4111.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 2694.00M | 2422.00M |
| Accumulated other comprehensive income | -305.00M | -387.00M | -425.00M | -490.00M | -404.00M |
| Common stock total equity | - | - | - | 3.00M | 3.00M |
| Retained earnings total equity | - | - | - | -2280.00M | -532.00M |
| Non currrent assets other | 5094.00M | 230.00M | 184.00M | 298.00M | 598.00M |
| Non current assets total | 47161.00M | 43099.00M | 41284.00M | 38795.00M | 37200.00M |
| Capital lease obligations | 2205.00M | 2206.00M | 2266.00M | 1752.00M | 1755.00M |
| Long term debt total | 43456.00M | 40196.00M | 39072.00M | 37714.00M | 34342.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | 72.00M | -4933.00M | -5317.00M | -3389.00M | -117.00M |
| Change to liabilities | - | - | - | -296.00M | 999.00M |
| Total cashflows from investing activities | -4988.00M | -4933.00M | -5317.00M | -3389.00M | -2643.00M |
| Net borrowings | 3287.00M | 3205.00M | 1295.00M | 3234.00M | 3255.00M |
| Total cash from financing activities | -8550.00M | -4582.00M | -4094.00M | -5656.00M | -6655.00M |
| Net income | 6784.00M | 6657.00M | 5242.00M | 6834.00M | 7721.00M |
| Change in cash | -893.00M | 998.00M | 27.00M | -543.00M | -342.00M |
| Begin period cash flow | 1933.00M | 935.00M | 908.00M | 1451.00M | 1793.00M |
| End period cash flow | 1040.00M | 1933.00M | 935.00M | 908.00M | 1451.00M |
| Total cash from operating activities | 12636.00M | 10514.00M | 9431.00M | 8522.00M | 8959.00M |
| Depreciation | 3523.00M | 3312.00M | 3077.00M | 2969.00M | 2853.00M |
| Other cashflows from investing activities | 12.00M | -120.00M | -131.00M | 1006.00M | -4.00M |
| Dividends paid | 679.00M | 690.00M | 661.00M | -653.00M | -624.00M |
| Change to inventory | -154.00M | 334.00M | -126.00M | -59.00M | -540.00M |
| Change to account receivables | -94.00M | -799.00M | -935.00M | -797.00M | -962.00M |
| Sale purchase of stock | -10067.00M | -6042.00M | -3811.00M | -7000.00M | -8215.00M |
| Other cashflows from financing activities | -1012.00M | -1055.00M | -917.00M | 4827.00M | -1071.00M |
| Change to netincome | - | - | - | -158.00M | -374.00M |
| Capital expenditures | 4944.00M | 4875.00M | 4744.00M | 4395.00M | 3577.00M |
| Change receivables | - | - | - | -797.00M | -962.00M |
| Cash and cash equivalents changes | - | - | - | -523.00M | -339.00M |
| Change in working capital | 728.00M | -106.00M | -457.00M | -1152.00M | -503.00M |
| Stock based compensation | 401.00M | 360.00M | 262.00M | 341.00M | 440.00M |
| Other non cash items | 1601.00M | 269.00M | 1340.00M | -1041.00M | -1482.00M |
| Free cash flow | 7692.00M | 5639.00M | 4687.00M | 4127.00M | 5382.00M |
Sector: Healthcare Industry: Medical Care Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| HCA HCA Healthcare, Inc. |
12.13 2.86% |
435.61 | 14.27 | 13.46 | 1.21 | 291.34 | 1.83 | 8.99 |
| THC Tenet Healthcare Corporation |
10.17 4.08% |
259.71 | 10.08 | 12.66 | 0.96 | 4.57 | 1.43 | 5.80 |
| FSNUY Fresenius SE & Co KGaA ADR |
0.11 0.84% |
13.27 | 16.87 | 9.44 | 0.42 | 0.78 | 0.79 | 5.37 |
| JDHIY JD Health International Inc |
- -% |
5.05 | 62.50 | 35.97 | 0.30 | 2.32 | 0.16 | 3.90 |
| FMCQF Fresenius Medical Care AG & Co. KGaA |
- -% |
44.58 | 14.21 | 9.00 | 0.78 | 0.77 | 0.98 | 5.67 |
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
One Park Plaza, Nashville, TN, United States, 37203
615 344 9551
230000
| Name | Title | Year Born |
|---|---|---|
| Mr. Samuel N. Hazen | CEO & Director | 1960 |
| Mr. William B. Rutherford | Exec. VP & CFO | 1964 |
| Mr. Charles J. Hall | Pres of National Group | 1953 |
| Mr. Jon Mack Foster | Pres of American Group | 1962 |
| Dr. Michael S. Cuffe M.B.A., M.D. | Exec. VP & Chief Clinical Officer | 1966 |
| Dr. Thomas F. Frist Jr. | Founder & Chairman Emeritus | 1939 |
| Mr. P. Martin Paslick | Sr. VP & Chief Information Officer | 1960 |
| Mr. Frank George Morgan C.F.A. | VP of Investor Relations | NA |
| Ms. Kathleen M. Whalen J.D. | Sr. VP and Chief Ethics & Compliance Officer | 1965 |
| Mr. Michael R. McAlevey | Sr. VP & Chief Legal Officer | 1964 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.